More than 2000 Maori from Rotorua and surrounding areas are set to be recruited for a groundbreaking study aimed at reducing smoking rates.
The University of Auckland study, which will use smokers from the Lakes District Health Board area, is one of the largest of its type and is set to test how effective a new, cheaper smoking aid is in helping people quit.
The study is seen as having great potential for improving Maori health in the region.
Lead researcher Associate Professor Natalie Walker from the University of Auckland's National Institute of Health Innovation, said the new aid, cytisine, was a much cheaper option to drugs currently on the market and might be more acceptable to Maori because it was found in the native kowhai plant - although it wouldn't be sourced from kowhai as part of the trial.
The "head-to-head trial" will compare the effective use of two quit smoking aids, cytisine and varenicline (which is used in Champix).